Alzheimer's Disease Trial, Recruiting NCT06338397 Sponsor: University Hospital, Lille Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06338397
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men and women between the ages of 40 and 85 (inclusive)
  • People registered with the French Social Security system
  • People who have a study partner available to complete several questionnaires or rating scales during the trial (travel costs will be covered by the trial organiser if either the participant or their study partner cannot drive)
  • People who are fluent in French and able to read and write

Who may not be able to join:

  • People for whom an MRI scan is not medically safe or suitable
  • People with significant sensory problems (such as hearing or vision difficulties) that cannot be adequately corrected with aids or devices
  • People whose dementia is caused by something other than a neurodegenerative disease, including those with a heavy burden of blood vessel-related risk factors, as judged by the investigator
  • People who have another neurodegenerative condition, such as Lewy body dementia or Parkinson's disease
  • People with another serious neurological condition, such as a brain tumour, stroke, epilepsy, or fluid build-up in the brain, or any other condition the investigator considers unsuitable for participation
  • People with excessive alcohol intake or drug misuse, as judged by the investigator
  • People who, in the investigator's opinion, may have difficulty following the trial procedures as required

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Thibaud LEBOUVIER, MD, PhD, University Hospital, Lille

Phone: 3.20.44.60.21

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 January 2025
Est. completion
28 January 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Correlation coefficient between the mini Social cognition & Emotional Assessment - mini-SEA - total score and the Social Behavior Observer Checklist - SBOC - score in all participants.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov